Pralsetinib: Treatment of metastatic RET fusion-positive non-small cell lung cancer
Publication Date
2022
Content Type
Article
PubMed ID:
Citation
American Journal of Health-System Pharmacy (2022) 79(7):527-533
2022
Article
American Journal of Health-System Pharmacy (2022) 79(7):527-533